Finally, the PD VPS35 D620N mutation enhances LRRK2 kinase activity toward its endogenous substrate RAB10 and VPS35 is required for LRRK2 kinase activity (Mir et al., 2018). This evidence concerns the gene LRRK2 and Parkinson disease.